is compound tirzepatide banned Compounded GLP-1 ban: What providers need to know The U.S. Food and Drug

These results have attracted widespread attention from both clinicians and the general public

One "unit" of semaglutide on a syringe is purely a volume measurement (0.01 mL)

Referral to a dermatologist may be appropriate for diagnostic uncertainty, severe or atypical presentations, suspected scarring alopecia, or cases not improving with conservative management

Through the end of safety follow-up in each trial, 0.6% of adults in each of the tirzepatide and placebo groups reported suicidal ideation, with most of these reports deemed low risk

The FDA's Office of Prescription Drug Promotion sent warning letters to Lilly, Novo Nordisk, and Hims & Hers over misleading GLP-1 promotion, part of a broader White House-directed crackdown that has included roughly 30 letters to telehealth and compounding operators and reported plans for dozens more